Results 151 to 160 of about 176,472 (336)

Characterization of arrhythmia‐induced cardiomyopathy using magnetic resonance imaging in patients with persistent atrial fibrillation and left ventricular systolic dysfunction – insights from DECAAF II

open access: yesEuropean Journal of Heart Failure, EarlyView.
Arrhythmia‐induced cardiomyopathy (AIC) in left ventricular systolic dysfunction with atrial fibrillation (AF). HFrEF, heart failure with reduced ejection fraction; LVEF, left ventricular ejection fraction; MRI, magnetic resonance imaging. Abstract Aims Atrial fibrillation (AF) ablation in heart failure reduces mortality and hospitalizations and ...
Ala Assaf   +14 more
wiley   +1 more source

Ventricular Tachycardia Ablation [PDF]

open access: yesCardiac Electrophysiology Clinics, 2017
Thakur R., Natale A.
openaire   +3 more sources

Genotype‐guided cardiac device intervention in LMNA‐related cardiac conduction disorder: The need for timely genetic testing

open access: yesEuropean Journal of Heart Failure, EarlyView.
Sudden cardiac death is a catastrophic event, making its prevention important. However, patient selection for primary prevention remains controversial. We report two cases of cardiac conduction disorder initially treated with permanent pacemaker implantation.
Shunsuke Inoue   +19 more
wiley   +1 more source

VENTRICULAR TACHYCARDIA [PDF]

open access: bronze, 1961
D. Scherf, Danielle F Tanner, M. Yildiz
openalex   +1 more source

Cardiac resynchronization therapy for enabling guideline‐directed medical therapy optimization in heart failure

open access: yesEuropean Journal of Heart Failure, EarlyView.
Cardiac resynchronization therapy (CRT) as an enabler for guideline‐directed medical therapy (GDMT) in the Swedish Heart Failure Registry (SwedeHF). The figure summarizes the selection of the study population, changes in GDMTs and loop diuretic use/doses from baseline to 1.5‐year follow‐up in patients receiving versus not receiving CRT, and reports the
Daniela Tomasoni   +17 more
wiley   +1 more source

Immune dysregulation as a key driver of peripartum cardiomyopathy – an exploratory advanced imaging and biomarker study

open access: yesEuropean Journal of Heart Failure, EarlyView.
Physiological postpartum remodelling and the pathological processes involved in peripartum cardiomyopathy (PPCM). 18FDG‐PET‐CT, 18F‐fluorodeoxyglucose positron emission tomography‐computed tomography; CCL3, chemokine (C‐C motif) ligand 3; CMR, cardiovascular magnetic resonance; CRP, C‐reactive protein; CSF‐1, colony‐stimulating factor 1; CXCL10 ...
Julian Hoevelmann   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy